Myasthenia gravis and community-acquired pneumonia: therapeutic challenges
{{output}}
Myasthenia gravis (MG) patients are highly susceptible to community-acquired pneumonia (CAP) due to the need for immunosuppressive therapies and aspiration risks, with CAP representing the leading infectious cause of mortality in this population. The intersect... ...